Navigation Links
Merial to Screen Chimerix' Chemical Library for Animal Health Drug Leads
Date:1/29/2008

DULUTH, Ga. and RESEARCH TRIANGLE PARK, N.C., Jan. 29 /PRNewswire/ -- Merial Limited and Chimerix, Inc. announced today that they have signed an agreement under which Merial will screen a Chimerix chemical library for animal health drug leads. Under the terms of this agreement, Merial has an option to negotiate a license with Chimerix for leads identified for possible animal health use.

"This collaboration with Chimerix provides us with an opportunity to further expand our ability to identify novel active compounds that will form the basis of new products designed to meet our customers' future needs," states Dr. Peter Hanson, Head of Pharmaceutical R&D.

"Collaborating with Merial, a known leader in animal health, will allow us to capitalize on active leads obtained through our chemical library for animal health indications that otherwise may not be developed," stated George Painter, President and CEO of Chimerix. "Our company is excited about the possibility of contributing to the development of a medication that will positively impact the health and well-being of animals."

About Merial

Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs more than 5,000 people and operates in more than 150 countries worldwide. Its 2007 sales were nearly $2.5 billion. Merial Limited is a joint venture between Merck & Co., Inc. and sanofi-aventis. For more information, please see http://www.merial.com.

About Chimerix

Chimerix, Inc. discovers, develops and commercializes therapeutics with enhanced pharmaceutical properties that are active against a broad range of viral diseases. Leveraging a powerful lipid, prodrug technology, ProLipTag(TM), Chimerix is able to develop drug candidates with oral-availability, increased potency and targeted delivery. These enhanced pharmaceutical properties can be applied to new drug moieties or known drugs to improve dosing parameters, broaden therapeutic applications and decrease the risk of adverse events. For more information, please see http://www.chimerix-inc.com.


'/>"/>
SOURCE Chimerix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
2. AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
3. BioReliance Launches Next-Generation Genotoxicity Screening Service
4. Diamics Receives European CE Mark Approval for Its Pap-Map(TM) System for Cervical Cancer Screening
5. Enigma Diagnostics to Develop Clinical Diagnostics Platform for UK National Chlamydia Screening Programme
6. Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy
7. Dude, big screen TVs, flexible electronics and surfboards made from same new material!
8. FED-TVs with carbon nanotube technology could supersede plasma and LCD flat screens
9. Siemens Unveils New Digital Mammography System for Optimized Screening
10. International Association of Fire Fighters (IAFF) Advocates Screening Fire Fighters for Carbon Monoxide Poisoning Using Pulse CO-Oximetry
11. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... NX Prenatal Inc., a US based ... for early warning of adverse pregnancy outcomes, announced ... by Dr. Thomas McElrath of Brigham ... Medicine,s (SMFM) annual meeting held in ... The presentation reported initial positive top-line results regarding ...
(Date:2/10/2016)... Tarrytown, New York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that ... discover and develop new vaccines and immunotherapies for infectious diseases and cancer. ...
(Date:2/10/2016)... , Feb. 10, 2016  Allergan plc (NYSE: ... that Brent Saunders , Allergan,s CEO and President, ... fireside chat session at the RBC Capital Markets Healthcare ... ET at The New York Palace Hotel in ... be webcast live and can be accessed on Allergan,s ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... across three states, announced today the promotion of two long-standing principal investigators (PI) ... of Family Medicine, Clinical Research and Development. , Dr. Laurence Chu, a Benchmark ...
Breaking Biology Technology:
(Date:1/22/2016)... , Jan. 22, 2016 ... addition of the "Global Biometrics Market ... their offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ... "Global Biometrics Market in Retail Sector ... --> Research and Markets ( ...
(Date:1/18/2016)... 2016  Extenua Inc., a pioneering developer of ... and access of ubiquitous on-premise and cloud storage, today ... Cyber.  ... C4ISR and Cyber initiatives in support of National ... technology solutions," said Steve Visconti , Extenua ...
(Date:1/11/2016)... CHICAGO , Jan. 11, 2016  higi, ... via nearly 10,000 retail locations, web and mobile, ... than $40 million from existing investors. ... will be devoted to further innovate higi,s health ... app and web portal – including expanding services ...
Breaking Biology News(10 mins):